Title : Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line.

Pub. Date : 2011 Mar

PMID : 23467537






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After treatment with PS-341, a proteasome inhibitor, the IkappaB degradation was inhibited, IkappaB expression increased, NF-kappaB and P-gp expression decreased in a time dependent manner. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
2 Compared to DNR group, the NF-kappaB p65 activity of DNR+PS-341 group was decreased. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
3 The mechanism may be that bortezomib decreases the degradation of IkappaB and the expression of NF-kappaB and P-gp, therefore induces the apoptosis of multi-drug resistant cells. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens